These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21669514)

  • 1. The socioeconomic consequences of multiple sclerosis: a controlled national study.
    Jennum P; Wanscher B; Frederiksen J; Kjellberg J
    Eur Neuropsychopharmacol; 2012 Jan; 22(1):36-43. PubMed ID: 21669514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The socioeconomic consequences of optic neuritis with and without multiple sclerosis: a controlled national study.
    Jennum P; Frederiksen JL; Wanscher B; Kjellberg J
    Acta Neurol Scand; 2013 Apr; 127(4):242-50. PubMed ID: 22812660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health, social, and economic consequences of neck injuries: a controlled national study evaluating societal effects on patients and their partners.
    Jennum P; Kjellberg J; Ibsen R; Bendix T
    Spine (Phila Pa 1976); 2013 Mar; 38(5):449-57. PubMed ID: 23238487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The socio-economical burden of hypersomnia.
    Jennum P; Kjellberg J
    Acta Neurol Scand; 2010 Apr; 121(4):265-70. PubMed ID: 20047573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health, social, and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners.
    Jennum P; Ibsen R; Petersen ER; Knudsen S; Kjellberg J
    Sleep Med; 2012 Sep; 13(8):1086-93. PubMed ID: 22841027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic and health consequences of COPD patients and their spouses in Denmark--1998-2010.
    Løkke A; Hilberg O; Kjellberg J; Ibsen R; Jennum P
    COPD; 2014 Jun; 11(3):237-46. PubMed ID: 24354969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.
    Rotstein Z; Hazan R; Barak Y; Achiron A
    Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic consequences of narcolepsy.
    Jennum P; Knudsen S; Kjellberg J
    J Clin Sleep Med; 2009 Jun; 5(3):240-5. PubMed ID: 19960645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost of multiple sclerosis in Australia.
    Taylor B; McDonald E; Fantino B; Sedal L; MacDonnell R; Pittas F; Groom T; Beresniak A
    J Clin Neurosci; 2007 Jun; 14(6):532-9. PubMed ID: 17430777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study.
    Jennum P; Ibsen R; Pedersen SW; Kjellberg J
    J Neurol; 2013 Mar; 260(3):785-93. PubMed ID: 23104122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of multiple sclerosis in the Czech Republic: the COMS study.
    Blahova Dusankova J; Kalincik T; Dolezal T; Kobelt G; Havrdova E
    Mult Scler; 2012 May; 18(5):662-8. PubMed ID: 21965424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and quality of life of multiple sclerosis in Switzerland.
    Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and quality of life of multiple sclerosis in Italy.
    Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The social and economic consequences of epilepsy: a controlled national study.
    Jennum P; Gyllenborg J; Kjellberg J
    Epilepsia; 2011 May; 52(5):949-56. PubMed ID: 21275976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and quality of life for patients with multiple sclerosis in Belgium.
    Kobelt G
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost evaluation of multiple sclerosis.
    Battaglia MA; Zagami P; Uccelli MM
    J Neurovirol; 2000 May; 6 Suppl 2():S191-3. PubMed ID: 10871812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health, social and economic consequences of polyneuropathy: a controlled national study evaluating societal effects on patients and their partners.
    Jennum P; Ibsen R; Kjellberg J
    Eur Neurol; 2015; 73(1-2):81-8. PubMed ID: 25401731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.